Close
New

Medscape is available in 5 Language Editions – Choose your Edition here.

 

Pediatric Pneumonia Workup

  • Author: Nicholas John Bennett, MBBCh, PhD, MA(Cantab), FAAP; Chief Editor: Russell W Steele, MD  more...
 
Updated: Jun 30, 2016
 

Approach Considerations

Diagnostic tests for pneumonia may include the following:

  • Pulse oximetry
  • Complete blood cell (CBC) count
  • Sputum and blood cultures
  • Serology
  • Chest radiography
  • Ultrasonography

Data show that point-of-care ultrasonography accurately diagnoses most cases of pneumonia in children and young adults. In a study of 200 babies, children, and young adults (≤21 years), ultrasonography had an overall sensitivity of 86% and a specificity of 89% for diagnosing pneumonia. Ultrasonography may eventually come to replace x-rays for diagnosis[1, 2, 29]

Identifying the causative infectious agent is the most valuable step in managing a complicated case of pneumonia. Unfortunately, an etiologic agent can be difficult to identify as various organisms cause pneumonia. Bacterial (including mycoplasmal, chlamydial, and acid fast), viral, and fungal infections are relatively common and have similar presentations, complicating clinical diagnosis. Furthermore, basic laboratory testing and radiologic testing are often not helpful in determining the etiology of pneumonia, and the treatments widely vary.

In patients with complicated pneumonia who have not had a treatment response or who require hospital admission, several diagnostic studies aimed at identifying the infectious culprit are warranted, including cultures, serology, a CBC count with the differential, and acute-phase reactant levels (erythrocyte sedimentation rate [ESR], C-reactive protein [CRP]).

Numerous factors may interfere with the ability to grow a likely pathogen in the microbiology laboratory, including (but not limited to) the following: pretreatment with antibiotics that limit in vitro but not in vivo growth, sputum contaminants that overgrow the pathogen, and pathogens that do not replicate in currently available culture systems. Techniques that may help overcome some of these limitations include antigen detection, nucleic acid probes, polymerase chain reaction (PCR)-based assays, or serologic tests.

Although once widely used, tests such as latex agglutination for detection of group B streptococcal antigen in urine, serum, or other fluids have fallen into disfavor because of poor predictive value; however, new generations of nonculture-based technologies continue to undergo development and may be more accurate and widely available in the future.

Next

Complete Blood Cell Count

Testing should include a CBC count with differential and evaluation of acute-phase reactants (ESR, CRP, or both) and sedimentation rate. The total white blood cell (WBC) count and differential may aid in determining if an infection is bacterial or viral, and, together with clinical symptoms, chest radiography, and ESR can be useful in monitoring the course of pneumonia. In cases of pneumococcal pneumonia, the WBC count is often elevated.

Before widespread pneumococcal immunization, Bachur et al observed that approximately 25% of febrile children with a WBC count of more than 20,000/µL, but without lower respiratory tract findings on examination, had radiographic pneumonia (termed occult pneumonia).[30] Although blood testing was obtained less frequently in the post-Prevnar era, recent studies by the same group demonstrated that leukocytosis was still associated with occult pneumonia.[31, 32]

Previous
Next

Sputum Gram Stain and Culture

Sputum is rarely produced in children younger than 10 years, and samples are always contaminated by oral flora. In the cooperative older child with a productive cough, a sputum Gram stain may be obtained (see the image below); however, very few children are able to cooperate with such a test. An adequate sputum culture should contain more than 25 PMN cells per field and fewer than 10 squamous cells per field.

(Left) Gram stain demonstrating gram-positive cocc (Left) Gram stain demonstrating gram-positive cocci in pairs and chains and (right) culture positive for Streptococcus pneumoniae.

In situations in which a microbiologic diagnosis is essential, endotracheal cultures and/or bronchoalveolar lavage culture can be sent for the isolation of offending pathogens. This is most important in patients with enigmatic and/or severe pneumonia, and it should be considered a priority in patients with compromised immune systems. Routine cultures for respiratory pathogens should be requested, along with special stains for PCP and special stains and cultures for Legionella, fungi, and acid-fast organisms. Viral cultures are also routinely requested.

Previous
Next

Blood Culture

Although blood cultures are technically easy to obtain and relatively noninvasive and nontraumatic, the results are rarely positive in the presence of pneumonia and even less so in cases of pretreated pneumonia. In a study of 168 patients with known pneumonia, Wubbel et al found only sterile blood cultures.[33]

In general, blood culture results are positive in less than 5% of patients with pneumococcal pneumonia. The percentage is even less in patients with Staphylococcus infection. However, a blood culture is still recommended in complicated cases of pneumonia. It may be the only way to identify the pathogen and its antimicrobial susceptibility patterns.

In neonates, blood culture with at least 1 mL of blood from an appropriately cleaned and prepared peripheral venous or arterial site is essential, because many neonatal pneumonias are hematogenous in origin and others serve as a focus for secondary seeding of the bloodstream. Older patients should have larger-volume blood culture samples obtained based on their age and the ease with which blood can be obtained. Blood culture samples obtained through freshly placed indwelling vascular catheters may be helpful, but they generally are discouraged because of the possibility of contamination with skin flora. Multiple cultures of blood from different sites and/or those drawn at different times may increase the culture yield.

Previous
Next

Serology

Because of the relatively low yield of cultures, more efforts are under way to develop quick and accurate serologic tests for common lung pathogens, such as M pneumoniae, Chlamydophila species, and Legionella.

In a Finnish study, of 278 patients diagnosed with community-acquired pneumonia, a total of 24 (9%) confirmed diagnoses of Mycoplasma infection were made, all of which had positive results with IgM-capture test with convalescent-phase serum.[34] Acute and convalescent serum samples were collected and tested using enzyme immunoassay for M pneumoniae IgM and IgG antibodies. Nasopharyngeal aspirates were tested using PCR and cultured with a Pneumofast kit.

Positive results were confirmed with Southern hybridization of PCR products and an IgM test with solid-phase antigen. Using an IgM-capture test in acute-phase serum, 79% of results were positive, 79% were positive using IgG serology, 50% positive using PCR, and 47% positive using culture.[34]

The authors of this study concluded that IgM serologic studies for Mycoplasma infection were not only quick but also sensitive and were the most valuable tools for diagnosis of M pneumoniae infection in any age group.[34] IgM serology is much more sensitive than cold agglutinin assessments, which are more commonly used to aid in the diagnosis of Mycoplasma infection and which demonstrate positive results in only 50% of cases.

Chlamydophila and Legionella species can be grown by experienced microbiologists; however, serologic testing is also routinely performed to support or establish the diagnosis. Similarly, lung infections caused by dimorphic fungi (eg, histoplasmosis) are more commonly diagnosed serologically.

Previous
Next

Inflammatory Markers

The use of markers of inflammation to support a diagnosis of suspected infection, including pneumonia, remains controversial because results are nonspecific. Various indices derived from differential leukocyte counts have been used most widely for this purpose, although noninfectious causes of such abnormal results are numerous. Many reports have been published regarding infants with proven infection who initially had neutrophil indices within reference ranges.

Quantitative measurements of CRP, procalcitonin, cytokines (eg, interleukin [IL]-6), inter-alpha inhibitor proteins (IaIp),[35] and batteries of acute-phase reactants have been touted to be more specific but are limited by suboptimal positive predictive value.

Lag time from infection to abnormal values are noted for inflammatory markers; thus, serial measurements are often necessary and do offer a high negative predictive value. However, although these tests may be useful in assessing the resolution of an inflammatory process, including infection, they are not sufficiently precise to establish a diagnosis without additional supporting information. Decisions about antimicrobial therapy should not be based on inflammatory markers alone.

Previous
Next

Polymerase Chain Reaction

Relatively rapid testing (1-2 d) of viral infections through multiplex PCR is available in many hospitals. PCR is more sensitive than antigen assays, and for some viruses (eg, hMPV), this study may be the only test available. PCR also shows promise of being useful in diagnosing streptococcal pneumonia. In one series of 63 children with empyema, a pathogen could be detected in 53 (84%) by PCR compared to only 24 (35%) by culture of blood and/or pleural fluid. The most frequently detected pathogen was pneumococcus, found in 45 patients.[36]

PCR is noninvasive, an advantage over lung aspirate or bronchoalveolar lavage (BAL) cultures. Similarly, C pneumoniae infection is diagnosed more readily with PCR than with culture; however, positive test results must correlate with acute symptoms to have any validity, because 2-5% of the population may be asymptomatically infected with C pneumoniae.

PCR testing for TB is also widely available and is helpful in early identification of TB from other mycobacteria in acid-fast cultures.

Previous
Next

Skin Testing

These tests are used in diagnosing TB. Mantoux skin test (intradermal [ID] inoculation of 5 tuberculin units [TU] of purified protein derivative [PPD]) results should be read 48-72 hours after placement.

Even if the child has received the BCG vaccine, Mantoux test results should be interpreted using the criteria outlined as follows. In children older than 4 years without any risk factors, test results are positive if the induration (not the area of erythema, which may be larger) is 15 mm or larger. Among children younger than 4 years, those who have an increased environmental exposure to TB or other medical risk factors (eg, lymphoma, diabetes mellitus, malnutrition, renal failure), results are positive if the induration is 10 mm or larger. In immunosuppressed children or those in close contact with others who have known or suspected cases of TB, test results are positive if the induration is 5 mm or larger. Chest radiography helps to confirm the diagnosis of a child with positive Mantoux test results (see Chest Radiography).

Previous
Next

Gastric Aspirates

In a child with suspected pulmonary TB, the cough may be scarce or nonproductive. Therefore, the best test for diagnosis is an early-morning gastric aspirate sent for acid-fast bacilli (AFB) stain, culture, and, if available, PCR. Gastric aspirates should be obtained by first placing a nasogastric (NG) tube the night before sample collection; a sample is aspirated first thing the following morning, before ambulation and feeding. This should be repeated on 3 consecutive mornings.

Previous
Next

Cold Agglutinin Testing

In the young child or school-aged child with pneumonia, particularly the patient with a gradual onset of symptoms and a prodrome consisting of headache and abdominal symptoms, a bedside cold agglutinins test may help confirm the clinical suspicion of mycoplasmal infection.

This test is easily performed by placing a small amount of blood in a specimen tube containing anticoagulant and inserting this into a cup filled with ice water. After a few minutes in the cold water, the tube is held up to the light, tilted slightly, and slowly rotated. Small clumps of RBCs coating the tube are indicative of a positive test result. Unfortunately, this test is positive in only half the cases of mycoplasmal infection, and it is not very specific.

Previous
Next

Urine Latex Agglutination Testing

Although antigen detection assays for S pneumoniae lack a high specificity in children, Neuman and Harper observed that 76% of febrile children with a lobar infiltrate on chest radiograph had a positive rapid urine antigen assay.[37]

Previous
Next

Direct Antigen Detection

Although antiviral therapies are not often used, performing a nasal wash or nasopharyngeal swab for RSV and influenza enzyme-linked immunoassay (ELISA) and viral culture can help to establish a rapid diagnosis, which may be helpful in excluding other causes. Viral cultures can be obtained in 1-2 days using newer cell culture techniques and may permit discontinuation of unnecessary antibiotics. In addition, correct diagnosis allows for appropriate placement of patients in the hospital. For example, if necessary, 2 infants with RSV infection may share a room, whereas such patients would normally need isolation and may unnecessarily tie up a bed.

Previous
Next

Chest Radiography

Chest radiography is indicated primarily in children with complications such as pleural effusions and in those in whom antibiotic treatment fails to elicit a response. Computed tomography (CT) scanning of the chest and ultrasonography are indicated in children with complications such as pleural effusions and in those in whom antibiotic treatment fails to elicit a response. For more information, see Imaging in Pediatric Pneumonia.

Previous
Next

Bronchoscopy

Flexible fiberoptic bronchoscopy is occasionally useful to obtain lower airway secretions for culture or cytology. This procedure is most useful in immunocompromised patients who are believed to be infected with unusual organisms (Pneumocystis, other fungi) or in patients who are severely ill.

The technique of direct rigid bronchoscopy may be used in larger infants; fiberoptic technique is occasionally possible in smaller infants or infants in whom the site is not easily reached using the rigid technique. Both this technique and protected brush tracheal aspirate sampling may not be well tolerated in infants with significant lung disease and poor gas exchange who are very dependent on continuous positive pressure ventilation.

Careful consideration of the diagnostic possibilities is necessary to send the samples for the appropriate tests. Contamination of the bronchoscopic aspirate with upper airway secretions is common; quantitative cultures can help distinguish contamination from infection. Culture and Gram stain of an endotracheal aspirate obtained by aseptic technique as soon as possible after intubation may be useful.

Under typical circumstances, airway commensals take as long as 8 hours to migrate down the trachea. At least one study demonstrated that culture of endotracheal aspirates obtained within 8 hours of birth correlates very well with blood culture results and probably reflects aspirated infected fluid.[38] The longer the tube has been in place, the greater the likelihood that recovered organisms represent colonizing organisms rather than invasive pathogens; nonetheless, recovery of a single recognized pathogen in large quantities may be helpful in the selection of antibiotic therapy, especially if culture results from normally sterile sites are negative.

The absence of significant inflammatory cells in an endotracheal aspirate or other respiratory specimen suggests that organisms recovered from that site are unlikely to be truly invasive (unless the infant is markedly leukopenic). Thus, the organism represents colonization of the respiratory tract and not infection.

Previous
Next

Bronchoscopic Alveolar Lavage

Quantitative culture techniques, such as bronchoscopic alveolar lavage have been assessed in non-neonatal populations and reportedly offer a specificity of more than 80%, depending on the threshold selected (values from >100-100,000 colony-forming units [CFU]/mL have been used).[39, 40] Data from studies of neonates with suspected congenital pneumonia are lacking.

Previous
Next

Protected Brush Tracheal Aspirate Sampling

Sites distant from the larger bronchi often cannot be sampled. Specimens may have an increased risk of contamination with oral or airway commensals compared with bronchoscopic sampling but are thought to be more accurate than a conventional endotracheal aspirate.

Nondirected specimens have been obtained through endotracheal tubes 3 mm or greater in internal diameter and intuitively appear to offer decreased probability of contamination. Data from neonates are sparse.[41] Unlike bronchoscopically obtained specimens, ensuring sampling from a particular involved site is more difficult.

Previous
Next

Lung Aspiration

Lung aspiration is underused and is a significantly more efficient method of obtaining a culture. If a prominent infiltrate can be adequately localized in multiple planes, direct aspiration of the infected lung may be performed for culture or biopsy. Lung CT scanning may facilitate such localization.

Lung aspiration is associated with a greater risk of postprocedural air leak and usually requires a larger-bore needle than is used to obtain pleural fluid. Because the risk associated with this procedure is high, lung aspiration is usually reserved for patients who are ill enough to require hospitalization, have not improved with previous empiric treatment, or are immunocompromised and an exact etiology is needed. A lung aspirate should not be performed in patients who are on ventilators, who have a bleeding diathesis, or who are suspected of having an infection with Pneumocystis.

With advances in surgical techniques and increased experience, many clinicians prefer to seek open surgical biopsy or thoracoscopic sampling in such circumstances, especially because success and specimen size are greater and the ability to deal directly with any complication is enhanced.

A study demonstrated positive blood cultures implicated an organism in 18% of patients compared with 52% with positive lung aspirates.[42] The investigators compared the incidence of positive culture results obtained with blood culture with positive culture results obtained with lung aspiration in 100 children aged 3-58 months with pneumonia. The organisms obtained in the blood and lung aspirate differed in 4 of 8 children in whom both culture results were positive, suggesting that a blood culture may not always accurately reveal the lung pathogen.[42]

Other studies have demonstrated lung aspirate results to be positive in 50-60% of patients with known pneumonia. In these studies, 1.5-9% of patients had a pneumothorax and 0.7-3% had transient small hemoptysis complicating their lung aspirations.

Previous
Next

Lung Puncture

Although used much less frequently than in previous decades, diagnostic lung puncture may still be useful in circumstances in which pleural and subpleural lung surfaces are visibly involved and can be well localized.[43] Risk-benefit ratio merits careful consideration given the risk of such complications as pneumothorax, bronchopleural fistula, and hemothorax, as well as sampling a nondiagnostic site. This is a high-risk procedure and should not be considered a routine procedure in the diagnosis or treatment of pneumonia in the neonate.

Previous
Next

Thoracentesis

This procedure is performed for diagnostic and therapeutic purposes in children with pleural effusions (eg, when pleural fluid is impinging on lung or cardiac function) (see the image below).

A breakdown of test results and recommended treatm A breakdown of test results and recommended treatment for pneumonia with effusion. Gm = Gram; neg = negative; pos = positive; VATS = video-assisted thoracic surgery

In the presence of radiographically visible fluid, careful positioning of the infant and thoracentesis after sterile preparation of the sampling site may yield diagnostic findings on Gram stain, direct microscopy, and/or culture. If the Gram stain or the culture result from the pleural fluid is positive or the WBC count is higher than 1000 cells/mL, by definition, the patient has an empyema, which may require drainage for complete resolution. Ultrasonography may reveal smaller fluid pockets and facilitate safer sampling under direct visualization. Although data from neonates are insufficient to draw conclusions, studies in older populations suggest a very high correlation with culture of lung tissue and/or blood. Other therapeutic decisions can be made based on the properties of the effusion (see Complications).

The risk of pneumothorax or laceration of intercostal vessels is real but can be minimized by the use of proper technique, including use of the Z-technique (stretching the skin down over the entry site, so that release after the procedure will permit the return of tissues to their usual location with occlusion of the path of the needle), entry over the superior rib margin (to minimize inadvertent puncture of intercostal vessels) at a dependent site where fluid is most likely to collect, continuous aspiration once the skin is penetrated, and no further advancement once fluid is obtained.

For more information, see Infections of the Lung, Pleura, and Mediastinum.

Previous
Next

Histology

No specific histologic findings are reported in most patients with pneumonias beyond evidence of inflammation and cellular infiltration and exudation into alveolar spaces and the interstitium. Sputum, lavage, or biopsy material may yield diagnostic findings.

Tissue samples of lung tissue in human infants have typically been obtained from an unrepresentative population. The sample population usually includes only infants with severe pulmonary disease that results in death or threatens to do so or infants who die of other causes and have coincidental sampling of the lung. Consequently, direct observations regarding histologic changes in mild or moderate pneumonia are sparse and are often supplemented by extrapolation from animal disease models, human adults with similar diseases, or more severe cases in human infants that resulted in death or biopsy. Despite these limitations, certain observations in congenital pneumonia recur, whether or not a specific pathogen is implicated.[44]

Macroscopically, the lung may have diffuse, multifocal, or very localized involvement with visibly increased density and decreased aeration. Frankly hemorrhagic areas and petechiae on pleural and intraparenchymal surfaces are common. Airway and intraparenchymal secretions may range from thin and watery to serosanguineous to frankly purulent, and they are frequently accompanied by small to moderate pleural effusions that display variable concentrations of inflammatory cells, protein, and glucose.

Frank empyema and abscesses are unusual in newborn infants. Particulate meconium or vernix may be visible, especially in the more proximal airways, following aspiration episodes. Superimposed changes, such as air leak, emphysema, and sloughed airway mucosa, may be seen as a consequence of volutrauma, pressure-related injury, oxygen toxicity, and other processes that reflect the vigorous respiratory support often provided to these infants in an attempt to manage derangements of gas exchange caused by the underlying illness.

With conventional microscopy, inflammatory cells are particularly prominent in the alveoli and airways. Mononuclear cells (macrophages, natural killer cells, small lymphocytes) are usually noted early, and granulocytes (eosinophils, neutrophils) typically become more prominent later. Microorganisms of variable viability or particulate debris may be observed within these cells. If systemic neutropenia is present, the number of inflammatory cells may be reduced. Alveoli may be atelectatic from surfactant destruction or dysfunction, partially expanded with proteinaceous debris (often resembling hyaline membranes), or hyperexpanded secondary to partial airway obstruction from inflammatory debris or meconium.

Hemorrhage in the alveoli and in distal airways is frequent. Vascular congestion is common; vasculitis and perivascular hemorrhage are seen less frequently. Inflammatory changes in interstitial tissues are less common in newborns than in older individuals.

Microscopic examination of tissue following immunohistochemical staining or other molecular biologic techniques can identify the herpes virus and an increasing number of other organisms. In patients with TB, acid-fast bacilli are present and can be detected using the Ziehl-Neelsen stain or can be grown on the Lowenstein-Jensen medium. Caseating granulomas are highly suspicious, even in the absence of detectable organisms. Findings of foamy alveolar casts are practically diagnostic for P jirovecii pneumonia, and the cup-shaped organisms are often found using Gomori methenamine silver staining or direct immunofluorescence.

Fungal elements may be seen using Gomori methenamine silver staining or periodic acid-Schiff (PAS) staining. Aspergillus and Zygomycetes species may be seen using simple hematoxylin and eosin (H&E) staining. The specific morphology of the organisms may be diagnostic, but, occasionally, culture or immunostaining is required.

Previous
 
 
Contributor Information and Disclosures
Author

Nicholas John Bennett, MBBCh, PhD, MA(Cantab), FAAP Assistant Professor of Pediatrics, Co-Director of Antimicrobial Stewardship, Medical Director, Division of Pediatric Infectious Diseases and Immunology, Connecticut Children's Medical Center

Nicholas John Bennett, MBBCh, PhD, MA(Cantab), FAAP is a member of the following medical societies: Alpha Omega Alpha, American Academy of Pediatrics

Disclosure: Received research grant from: Cubist Pharmaceuticals, Durata Therapeutics, and Biota Pharmaceutical<br/>Received income in an amount equal to or greater than $250 from: HealthyCT insurance<br/>Medico legal consulting for: Various.

Coauthor(s)

Joseph Domachowske, MD Professor of Pediatrics, Microbiology and Immunology, Department of Pediatrics, Division of Infectious Diseases, State University of New York Upstate Medical University

Joseph Domachowske, MD is a member of the following medical societies: Alpha Omega Alpha, American Academy of Pediatrics, American Society for Microbiology, Infectious Diseases Society of America, Pediatric Infectious Diseases Society, Phi Beta Kappa

Disclosure: Received research grant from: Pfizer;GlaxoSmithKline;AstraZeneca;Merck;American Academy of Pediatrics<br/>Received income in an amount equal to or greater than $250 from: Sanofi Pasteur;Astra Zeneca;Novartis<br/>Consulting fees for: Sanofi Pasteur; Novartis; Merck; Astra Zeneca.

Chief Editor

Russell W Steele, MD Clinical Professor, Tulane University School of Medicine; Staff Physician, Ochsner Clinic Foundation

Russell W Steele, MD is a member of the following medical societies: American Academy of Pediatrics, American Association of Immunologists, American Pediatric Society, American Society for Microbiology, Infectious Diseases Society of America, Louisiana State Medical Society, Pediatric Infectious Diseases Society, Society for Pediatric Research, Southern Medical Association

Disclosure: Nothing to disclose.

Acknowledgements

Leslie L Barton, MD Professor Emerita of Pediatrics, University of Arizona College of Medicine

Leslie L Barton, MD is a member of the following medical societies: American Academy of Pediatrics, Association of Pediatric Program Directors, Infectious Diseases Society of America, and Pediatric Infectious Diseases Society

Disclosure: Nothing to disclose.

Heidi Connolly, MD Associate Professor of Pediatrics and Psychiatry, University of Rochester School of Medicine and Dentistry; Director, Pediatric Sleep Medicine Services, Strong Sleep Disorders Center

Disclosure: Nothing to disclose.

Brent R King , MD, MMM Clive Nancy and Pierce Runnells Distinguished Professor of Emergency Medicine; Professor of Pediatrics, University of Texas Health Science Center at Houston; Chair, Department of Emergency Medicine, Chief of Emergency Services, Memorial Hermann Hospital and LBJ Hospital

Disclosure: Nothing to disclose.

Jeff L Myers, MD, PhD Chief, Pediatric and Congenital Cardiac Surgery, Department of Surgery, Massachusetts General Hospital; Associate Professor of Surgery, Harvard Medical School

Disclosure: Nothing to disclose.

Mark I Neuman, MD, MPH Assistant Professor of Pediatrics, Harvard Medical School; Attending Physician, Division of Emergency Medicine, Children's Hospital Boston

Mark I Neuman, MD, MPH is a member of the following medical societies: Society for Pediatric Research

Disclosure: Nothing to disclose.

José Rafael Romero, MD Director of Pediatric Infectious Diseases Fellowship Program, Associate Professor, Department of Pediatrics, Combined Division of Pediatric Infectious Diseases, Creighton University/University of Nebraska Medical Center

José Rafael Romero, MD is a member of the following medical societies: American Academy of Pediatrics, American Society for Microbiology, Infectious Diseases Society of America, New York Academy of Sciences, and Pediatric Infectious Diseases Society

Disclosure: Nothing to disclose.

Manika Suryadevara, MD Fellow in Pediatric Infectious Diseases, Department of Pediatrics, State University of New York Upstate Medical University

Disclosure: Nothing to disclose.

Isabel Virella-Lowell, MD Department of Pediatrics, Division of Pulmonary Diseases, Pediatric Pulmonology, Allergy and Immunology

Disclosure: Nothing to disclose.

Garry Wilkes, MBBS, FACEM Director of Emergency Medicine, Calvary Hospital, Canberra, ACT; Adjunct Associate Professor, Edith Cowan University, Western Australia

Disclosure: Nothing to disclose.

Mary L Windle, PharmD Adjunct Associate Professor, University of Nebraska Medical Center College of Pharmacy; Editor-in-Chief, Medscape Drug Reference

Disclosure: Nothing to disclose.

Grace M Young, MD Associate Professor, Department of Pediatrics, University of Maryland Medical Center

Disclosure: Nothing to disclose.

References
  1. Boggs W. Point-of-Care Ultrasound Diagnoses Pneumonia in Children. Medscape Medical News. December 10, 2012. Available at http://www.medscape.com/viewarticle/775961. Accessed: January 9, 2013.

  2. Shah VP, Tunik MG, Tsung JW. Prospective Evaluation of Point-of-Care Ultrasonography for the Diagnosis of Pneumonia in Children and Young Adults. Arch Pediatr Adolesc Med. 2012 Dec 10. 1-7. [Medline].

  3. Metinko AP. Neonatal pulmonary host defense mechanisms. Polin RA, Fox WW, eds. Fetal and Neonatal Physiology. 3rd ed. Philadelphia, Pa: WB Saunders Co; 2004. 1620-73.

  4. Barnett ED, Klein JO. Bacterial infections of the respiratory tract. Remington JS, Klein JO, eds. Infectious Diseases of the Fetus and Newborn Infant. 6th ed. Philadelphia, Pa: Elsevier Saunders Co; 2006. 297-317.

  5. Bone RC, Grodzin CJ, Balk RA. Sepsis: a new hypothesis for pathogenesis of the disease process. Chest. 1997 Jul. 112(1):235-43. [Medline].

  6. Michelow IC, Olsen K, Lozano J, Rollins NK, Duffy LB, Ziegler T, et al. Epidemiology and clinical characteristics of community-acquired pneumonia in hospitalized children. Pediatrics. 2004 Apr. 113(4):701-7. [Medline].

  7. Stoll BJ, Hansen NI, Higgins RD, Fanaroff AA, Duara S, Goldberg R, et al. Very low birth weight preterm infants with early onset neonatal sepsis: the predominance of gram-negative infections continues in the National Institute of Child Health and Human Development Neonatal Research Network, 2002-2003. Pediatr Infect Dis J. 2005 Jul. 24(7):635-9. [Medline].

  8. Mishaan AM, Mason EO Jr, Martinez-Aguilar G, Hammerman W, Propst JJ, Lupski JR, et al. Emergence of a predominant clone of community-acquired Staphylococcus aureus among children in Houston, Texas. Pediatr Infect Dis J. 2005 Mar. 24(3):201-6. [Medline].

  9. Kotecha S, Hodge R, Schaber JA, Miralles R, Silverman M, Grant WD. Pulmonary Ureaplasma urealyticum is associated with the development of acute lung inflammation and chronic lung disease in preterm infants. Pediatr Res. 2004 Jan. 55(1):61-8. [Medline].

  10. Katz B, Patel P, Duffy L, Schelonka RL, Dimmitt RA, Waites KB. Characterization of ureaplasmas isolated from preterm infants with and without bronchopulmonary dysplasia. J Clin Microbiol. 2005 Sep. 43(9):4852-4. [Medline]. [Full Text].

  11. Heggie AD, Bar-Shain D, Boxerbaum B, Fanaroff AA, O'Riordan MA, Robertson JA. Identification and quantification of ureaplasmas colonizing the respiratory tract and assessment of their role in the development of chronic lung disease in preterm infants. Pediatr Infect Dis J. 2001 Sep. 20(9):854-9. [Medline].

  12. Ballard HO, Bernard P, Whitehead V, et al. Determining the incidence of Ureaplasma spp. and its role in development of bronchopulmonary dysplasia. [Abstract 3858.111]. Pediatric Academic Societies Meeting 2009. Baltimore, MD. May 3, 2009. aps-spr.org. Available at http://www.abstracts2view.com/pas/view.php?nu=PAS09L1_3037. Accessed: November 5, 2010.

  13. Tsolia MN, Psarras S, Bossios A, Audi H, Paldanius M, Gourgiotis D, et al. Etiology of community-acquired pneumonia in hospitalized school-age children: evidence for high prevalence of viral infections. Clin Infect Dis. 2004 Sep 1. 39(5):681-6. [Medline].

  14. Nascimento-Carvalho CM, Ribeiro CT, Cardoso MR, Barral A, Araújo-Neto CA, Oliveira JR, et al. The role of respiratory viral infections among children hospitalized for community-acquired pneumonia in a developing country. Pediatr Infect Dis J. 2008 Oct. 27(10):939-41. [Medline].

  15. Juvén T, Mertsola J, Waris M, Leinonen M, Meurman O, Roivainen M, et al. Etiology of community-acquired pneumonia in 254 hospitalized children. Pediatr Infect Dis J. 2000 Apr. 19(4):293-8. [Medline].

  16. [Guideline] American Academy of Pediatrics Committee on Infectious Diseases. Recommended childhood and adolescent immunization schedules--United States, 2009. Pediatrics. 2009 Jan. 123(1):189-90. [Medline].

  17. Tajima T, Nakayama E, Kondo Y, Hirai F, Ito H, Iitsuka T, et al. Etiology and clinical study of community-acquired pneumonia in 157 hospitalized children. J Infect Chemother. 2006 Dec. 12(6):372-9. [Medline].

  18. Thomson J, Hall M, Ambroggio L, Stone B, Srivastava R, Shah SS, et al. Aspiration and Non-Aspiration Pneumonia in Hospitalized Children With Neurologic Impairment. Pediatrics. 2016 Feb. 137 (2):1-10. [Medline].

  19. Denny FW, Clyde WA Jr. Acute lower respiratory tract infections in nonhospitalized children. J Pediatr. 1986 May. 108(5 Pt 1):635-46. [Medline].

  20. Thompson WW, Shay DK, Weintraub E, Brammer L, Bridges CB, Cox NJ, et al. Influenza-associated hospitalizations in the United States. JAMA. 2004 Sep 15. 292(11):1333-40. [Medline].

  21. Black SB, Shinefield HR, Ling S, Hansen J, Fireman B, Spring D, et al. Effectiveness of heptavalent pneumococcal conjugate vaccine in children younger than five years of age for prevention of pneumonia. Pediatr Infect Dis J. 2002 Sep. 21(9):810-5. [Medline].

  22. Li ST, Tancredi DJ. Empyema hospitalizations increased in US children despite pneumococcal conjugate vaccine. Pediatrics. 2010 Jan. 125(1):26-33. [Medline].

  23. Rudan I, Tomaskovic L, Boschi-Pinto C, Campbell H. Global estimate of the incidence of clinical pneumonia among children under five years of age. Bull World Health Organ. 2004 Dec. 82(12):895-903. [Medline]. [Full Text].

  24. Shah S, Bachur R, Kim D, Neuman MI. Lack of predictive value of tachypnea in the diagnosis of pneumonia in children. Pediatr Infect Dis J. 2010 May. 29(5):406-9. [Medline].

  25. Wingerter SL, Bachur RG, Monuteaux MC, Neuman MI. Application of the World Health Organization Criteria to Predict Radiographic Pneumonia in a US-based Pediatric Emergency Department. Pediatr Infect Dis J. 2012 Jun. 31(6):561-4. [Medline].

  26. Lynch T, Platt R, Gouin S, Larson C, Patenaude Y. Can we predict which children with clinically suspected pneumonia will have the presence of focal infiltrates on chest radiographs?. Pediatrics. 2004 Mar. 113(3 Pt 1):e186-9. [Medline].

  27. Mahabee-Gittens EM, Grupp-Phelan J, Brody AS, Donnelly LF, Bracey SE, Duma EM, et al. Identifying children with pneumonia in the emergency department. Clin Pediatr (Phila). 2005 Jun. 44(5):427-35. [Medline].

  28. Rothrock SG, Green SM, Fanelli JM, Cruzen E, Costanzo KA, Pagane J. Do published guidelines predict pneumonia in children presenting to an urban ED?. Pediatr Emerg Care. 2001 Aug. 17(4):240-3. [Medline].

  29. Jones BP, Tay ET, Elikashvili I, Sanders JE, Paul AZ, Nelson BP, et al. Feasibility and Safety of Substituting Lung Ultrasound for Chest X-ray When Diagnosing Pneumonia in Children: A Randomized Controlled Trial. Chest. 2016 Feb 25. [Medline].

  30. Bachur R, Perry H, Harper MB. Occult pneumonias: empiric chest radiographs in febrile children with leukocytosis. Ann Emerg Med. 1999 Feb. 33(2):166-73. [Medline].

  31. Murphy CG, van de Pol AC, Harper MB, Bachur RG. Clinical predictors of occult pneumonia in the febrile child. Acad Emerg Med. 2007 Mar. 14(3):243-9. [Medline].

  32. Rutman MS, Bachur R, Harper MB. Radiographic pneumonia in young, highly febrile children with leukocytosis before and after universal conjugate pneumococcal vaccination. Pediatr Emerg Care. 2009 Jan. 25(1):1-7. [Medline].

  33. Wubbel L, Muniz L, Ahmed A, Trujillo M, Carubelli C, McCoig C, et al. Etiology and treatment of community-acquired pneumonia in ambulatory children. Pediatr Infect Dis J. 1999 Feb. 18(2):98-104. [Medline].

  34. Waris ME, Toikka P, Saarinen T, Nikkari S, Meurman O, Vainionpää R, et al. Diagnosis of Mycoplasma pneumoniae pneumonia in children. J Clin Microbiol. 1998 Nov. 36(11):3155-9. [Medline]. [Full Text].

  35. Chaaban H, Singh K, Huang J, Siryaporn E, Lim YP, Padbury JF. The role of inter-alpha inhibitor proteins in the diagnosis of neonatal sepsis. J Pediatr. 2009 Apr. 154(4):620-622.e1. [Medline].

  36. Blaschke AJ, Heyrend C, Byington CL, Obando I, Vazquez-Barba I, Doby EH, et al. Molecular analysis improves pathogen identification and epidemiologic study of pediatric parapneumonic empyema. Pediatr Infect Dis J. 2011 Apr. 30(4):289-94. [Medline]. [Full Text].

  37. Neuman MI, Harper MB. Evaluation of a rapid urine antigen assay for the detection of invasive pneumococcal disease in children. Pediatrics. 2003 Dec. 112(6 Pt 1):1279-82. [Medline].

  38. Sherman MP, Goetzman BW, Ahlfors CE, Wennberg RP. Tracheal asiration and its clinical correlates in the diagnosis of congenital pneumonia. Pediatrics. 1980 Feb. 65(2):258-63. [Medline].

  39. Gauvin F, Dassa C, Chaïbou M, Proulx F, Farrell CA, Lacroix J. Ventilator-associated pneumonia in intubated children: comparison of different diagnostic methods. Pediatr Crit Care Med. 2003 Oct. 4(4):437-43. [Medline].

  40. Gauvin F, Lacroix J, Guertin MC, Proulx F, Farrell CA, Moghrabi A, et al. Reproducibility of blind protected bronchoalveolar lavage in mechanically ventilated children. Am J Respir Crit Care Med. 2002 Jun 15. 165(12):1618-23. [Medline].

  41. Labenne M, Poyart C, Rambaud C, Goldfarb B, Pron B, Jouvet P, et al. Blind protected specimen brush and bronchoalveolar lavage in ventilated children. Crit Care Med. 1999 Nov. 27(11):2537-43. [Medline].

  42. Falade AG, Mulholland EK, Adegbola RA, Greenwood BM. Bacterial isolates from blood and lung aspirate cultures in Gambian children with lobar pneumonia. Ann Trop Paediatr. 1997 Dec. 17(4):315-9. [Medline].

  43. Klein JO. Diagnostic lung puncture in the pneumonias of infants and children. Pediatrics. 1969 Oct. 44(4):486-92. [Medline].

  44. Wigglesworth JS. Perinatal Pathology. 2nd ed. Philadelphia, Pa: WB Saunders Co; 1996. 131-57, 184-7.

  45. Bradley JS, Byington CL, Shah SS, et al. The management of community-acquired pneumonia in infants and children older than 3 months of age: clinical practice guidelines by the pediatric infectious diseases society and the infectious diseases society of america. Clin Infect Dis. 2011 Oct. 53(7):e25-76. [Medline].

  46. Willwerth BM, Harper MB, Greenes DS. Identifying hospitalized infants who have bronchiolitis and are at high risk for apnea. Ann Emerg Med. 2006 Oct. 48(4):441-7. [Medline].

  47. Muszynski JA, Knatz NL, Sargel CL, Fernandez SA, Marquardt DJ, Hall MW. Timing of correct parenteral antibiotic initiation and outcomes from severe bacterial community-acquired pneumonia in children. Pediatr Infect Dis J. 2011 Apr. 30(4):295-301. [Medline].

  48. [Guideline] Cincinnati Children''s Hospital Medical Center. Evidence based care guideline for community acquired pneumonia in children 60 days through 17 years of age. Cincinnati (OH): Cincinnati Children''s Hospital Medical Center. Jul. 2006. Available at http://guideline.gov/index.aspx. Accessed: September 22, 2010.

  49. Neuman MI, Kelley M, Harper MB, File TM Jr, Camargo CA Jr. Factors associated with antimicrobial resistance and mortality in pneumococcal bacteremia. J Emerg Med. 2007 May. 32(4):349-57. [Medline]. [Full Text].

  50. Barber J Jr. Narrow-Spectrum Antibiotics Effective for Pediatric Pneumonia. Medscape Medical News. Oct 29 2013. [Full Text].

  51. Williams DJ, Hall M, Shah SS, et al. Narrow Vs broad-spectrum antimicrobial therapy for children hospitalized with pneumonia. Pediatrics. 2013 Nov. 132(5):e1141-8. [Medline].

  52. Braude AC, Hornstein A, Klein M, Vas S, Rebuck AS. Pulmonary disposition of tobramycin. Am Rev Respir Dis. 1983 May. 127(5):563-5. [Medline].

  53. Pennington JE. Penetration of antibiotics into respiratory secretions. Rev Infect Dis. 1981 Jan-Feb. 3(1):67-73. [Medline].

  54. Clark RH, Bloom BT, Spitzer AR, Gerstmann DR. Empiric use of ampicillin and cefotaxime, compared with ampicillin and gentamicin, for neonates at risk for sepsis is associated with an increased risk of neonatal death. Pediatrics. 2006 Jan. 117(1):67-74. [Medline].

  55. Siempos II, Vardakas KZ, Kopterides P, Falagas ME. Adjunctive therapies for community-acquired pneumonia: a systematic review. J Antimicrob Chemother. 2008 Oct. 62(4):661-8. [Medline].

  56. Black S, Shinefield H, Fireman B, Lewis E, Ray P, Hansen JR, et al. Efficacy, safety and immunogenicity of heptavalent pneumococcal conjugate vaccine in children. Northern California Kaiser Permanente Vaccine Study Center Group. Pediatr Infect Dis J. 2000 Mar. 19(3):187-95. [Medline].

  57. FDA. FDA Approves Pneumococcal Disease Vaccine with Broader Protection. February 24, 2010. Available at http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm201758.htm. Accessed: September 22, 2010.

  58. Melville N.A. Pneumonia Vaccine Benefits Extend to Unvaccinated Children. Medscape Medical News. Available at http://www.medscape.com/viewarticle/845102. Accessed: May 28, 2015.

  59. Lassi ZS, Haider BA, Bhutta ZA. Zinc supplementation for the prevention of pneumonia in children aged 2 months to 59 months. Cochrane Database Syst Rev. 2010 Dec 8. CD005978. [Medline].

  60. Douglas D. Twice-Daily Amoxicillin Effective in Children With Pneumonia. Medscape Medical News. Available at http://www.medscape.com/viewarticle/823469. Accessed: April 22, 2014.

  61. Vilas-Boas AL, Fontoura MS, Xavier-Souza G, Araújo-Neto CA, Andrade SC, Brim RV, et al. Comparison of oral amoxicillin given thrice or twice daily to children between 2 and 59 months old with non-severe pneumonia: a randomized controlled trial. J Antimicrob Chemother. 2014 Mar 19. [Medline].

  62. Addo-Yobo E, Chisaka N, Hassan M, Hibberd P, Lozano JM, Jeena P, et al. Oral amoxicillin versus injectable penicillin for severe pneumonia in children aged 3 to 59 months: a randomised multicentre equivalency study. Lancet. 2004 Sep 25-Oct 1. 364(9440):1141-8. [Medline].

  63. Brasfield DM, Stagno S, Whitley RJ, Cloud G, Cassell G, Tiller RE. Infant pneumonitis associated with cytomegalovirus, Chlamydia, Pneumocystis, and Ureaplasma: follow-up. Pediatrics. 1987 Jan. 79(1):76-83. [Medline].

  64. Brewster DR, De Silva LM, Henry RL. Chlamydia trachomatis and respiratory disease in infants. Med J Aust. 1981 Oct 3. 2(7):328-30. [Medline].

  65. Cevey-Macherel M, Galetto-Lacour A, Gervaix A, Siegrist CA, Bille J, Bescher-Ninet B, et al. Etiology of community-acquired pneumonia in hospitalized children based on WHO clinical guidelines. Eur J Pediatr. 2009 Dec. 168(12):1429-36. [Medline].

  66. Courtoy I, Lande AE, Turner RB. Accuracy of radiographic differentiation of bacterial from nonbacterial pneumonia. Clin Pediatr (Phila). 1989 Jun. 28(6):261-4. [Medline].

  67. de Man P, Verhoeven BA, Verbrugh HA, Vos MC, van den Anker JN. An antibiotic policy to prevent emergence of resistant bacilli. Lancet. 2000 Mar 18. 355(9208):973-8. [Medline].

  68. Fasoli L, Paldanius M, Don M, Valent F, Vetrugno L, Korppi M, et al. Simkania negevensis in community-acquired pneumonia in Italian children. Scand J Infect Dis. 2008. 40(3):269-72. [Medline].

  69. Gückel C, Benz-Bohm G, Widemann B. Mycoplasmal pneumonias in childhood. Roentgen features, differential diagnosis and review of literature. Pediatr Radiol. 1989. 19(8):499-503. [Medline].

  70. Haney PJ, Bohlman M, Sun CC. Radiographic findings in neonatal pneumonia. AJR Am J Roentgenol. 1984 Jul. 143(1):23-6. [Medline].

  71. Hansen J, Black S, Shinefield H, Cherian T, Benson J, Fireman B, et al. Effectiveness of heptavalent pneumococcal conjugate vaccine in children younger than 5 years of age for prevention of pneumonia: updated analysis using World Health Organization standardized interpretation of chest radiographs. Pediatr Infect Dis J. 2006 Sep. 25(9):779-81. [Medline].

  72. Korppi M, Kiekara O, Heiskanen-Kosma T, Soimakallio S. Comparison of radiological findings and microbial aetiology of childhood pneumonia. Acta Paediatr. 1993 Apr. 82(4):360-3. [Medline].

  73. Mathews B, Shah S, Cleveland RH, Lee EY, Bachur RG, Neuman MI. Clinical predictors of pneumonia among children with wheezing. Pediatrics. 2009 Jul. 124(1):e29-36. [Medline].

  74. Puumalainen T, Quiambao B, Abucejo-Ladesma E, Lupisan S, Heiskanen-Kosma T, Ruutu P, et al. Clinical case review: a method to improve identification of true clinical and radiographic pneumonia in children meeting the World Health Organization definition for pneumonia. BMC Infect Dis. 2008 Jul 21. 8:95. [Medline]. [Full Text].

  75. Radkowski MA, Kranzler JK, Beem MO, Tipple MA. Chlamydia pneumonia in infants: radiography in 125 cases. AJR Am J Roentgenol. 1981 Oct. 137(4):703-6. [Medline].

  76. Wahlgren H, Mortensson W, Eriksson M, Finkel Y, Forsgren M, Leinonen M. Radiological findings in children with acute pneumonia: age more important than infectious agent. Acta Radiol. 2005 Jul. 46(4):431-6. [Medline].

  77. Wildin SR, Chonmaitree T, Swischuk LE. Roentgenographic features of common pediatric viral respiratory tract infections. Am J Dis Child. 1988 Jan. 142(1):43-6. [Medline].

  78. Wolf DG, Greenberg D, Shemer-Avni Y, Givon-Lavi N, Bar-Ziv J, Dagan R. Association of human metapneumovirus with radiologically diagnosed community-acquired alveolar pneumonia in young children. J Pediatr. 2010 Jan. 156(1):115-20. [Medline].

  79. World Health Organization. Handbook. IMCI integrated management of childhood illness. Available at http://whqlibdoc.who.int/publications/2005/9241546441.pdf. Accessed: November 5,2010.

 
Previous
Next
 
(Left) Gram stain demonstrating gram-positive cocci in pairs and chains and (right) culture positive for Streptococcus pneumoniae.
A breakdown of test results and recommended treatment for pneumonia with effusion. Gm = Gram; neg = negative; pos = positive; VATS = video-assisted thoracic surgery
(A) Anteroposterior radiograph from a child with presumptive viral pneumonia. (B) Lateral radiograph of the same child with presumptive viral pneumonia.
Radiograph from a patient with bacterial pneumonia (same patient as in the preceding image) a few days later. This radiograph reveals progression of pneumonia into the right middle lobe and the development of a large parapneumonic pleural effusion.
Right lower lobe consolidation in a patient with bacterial pneumonia.
(A) Anteroposterior radiograph from a child with a left lower lobe infiltrate. (B) Lateral radiograph of the same child with a left lower lobe infiltrate.
Anteroposterior radiograph from a child with a round pneumonia.
Table. Categorizing Patients Based on Symptoms, Which Assists in Differential Diagnosis of Those With Recurrent Pneumonias
Category Laboratory and Imaging Findings Clinical Findings Differential Diagnosis
1 Persistent or recurrent radiologic findings Persistent or recurrent fever and symptoms Cystic fibrosis, immunodeficiencies, obstruction (intrinsic [eg, foreign body] or extrinsic [eg, compressing nodes or tumor]), pulmonary sequestration, bronchial stenosis, or bronchiectasis
2 Persistent radiologic findings No clinical findings Anatomic abnormality (eg, sequestration, fibrosis, pleural lesion)
3 Recurrent pulmonary infiltrates with interval radiologic clearing No clinical findings Asthma and atelectasis that has been misdiagnosed as a bacterial pneumonia; aspiration syndrome, hypersensitivity pneumonitis, idiopathic pulmonary hemosiderosis, or a mild immunodeficiency disorder
Previous
Next
 
 
 
 
 
All material on this website is protected by copyright, Copyright © 1994-2016 by WebMD LLC. This website also contains material copyrighted by 3rd parties.